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Abstract
Purpose—Examine whether maternal asthma contributes to racial/ethnic differences in obstetric 
and neonatal complications.
Methods—Data on White (n=110,603), Black (n=50,284) and Hispanic (n=38,831) singleton 
deliveries came from the Consortium on Safe Labor. Multi-level logistic regression models, with 
an interaction term for asthma and race/ethnicity, estimated within-group adjusted odds ratios 
(aOR) for gestational diabetes, gestational hypertension, preeclampsia, placental abruption, 
premature rupture of membranes, preterm delivery, maternal hemorrhage, NICU admissions, 
small for gestational age (SGA), apnea, respiratory distress syndrome, transient tachypnea of the 
newborn, anemia and hyperbilirubinemia after adjustment for clinical and demographic 
confounders. Non-asthmatics of the same racial/ethnic group were the reference group.
Results—Compared to non-asthmatics, White asthmatics had increased odds of preeclampsia 
(aOR 1.28; 95% CI: 1.15–1.43) and maternal hemorrhage (1.14; 1.04–1.23). White and Hispanic 
infants were more likely to have NICU admissions (1.19; 1.11–1.28; 1.16; 1.02–1.32, 
respectively) and be SGA (1.11; 1.02–1.20; 1.26; 1.10–1.44, respectively) and Hispanic infants 
were more likely to have apnea (1.32; 1.02–1.69).
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Conclusions—Maternal asthma did not impact most obstetric and neonatal complication risks 
within racial/ethnic groups. Despite their increased risk for both asthma and many complications, 
our findings for Black women were null. Asthma did not contribute to racial/ethnic disparities in 
complications.
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asthma; pregnancy; infant; ethnic groups; health disparities
Introduction
Asthma is the most common chronic disease during pregnancy, complicating up to 12% of 
US pregnancies annually [1, 2]. Maternal asthma has been found to increase the risk of 
obstetric and neonatal complications such as preterm birth, preeclampsia, gestational 
diabetes, and low birth weight [1, 3–5]. Asthma also disproportionately affects certain racial/
ethnic groups. For instance, Non-Hispanic Blacks have a higher prevalence of asthma 
compared with Whites (11.2% vs 7.7%), Hispanics (6.5%) or Asians (5.2%) [6].
Racial/ethnic disparities in maternal and neonatal morbidity and mortality are also well 
established and have been found to persist [7–9]. For instance, while infant mortality rates 
have declined in the US, the 2010 mortality rate for Black infants of 11.5 deaths per 1000 
live births remains more than twice the rate reported for infants born to Non-Hispanic 
Whites (5.18), Hispanics (5.25) and Asian/Pacific Islanders (4.27) [10]. In addition, a multi-
state analysis found rates of severe maternal morbidity per 10,000 delivery hospitalizations 
among Non-Hispanic Black (284.26) and American Indian/Alaska Native women (225.47) 
were much higher than among Non-Hispanic Whites (113.93) with intermediate rates 
observed for Hispanic (145.28) and Asian/Pacific Islander women (131.97) [11].
Examining the extent to which underlying racial/ethnic disparities in obstetric and neonatal 
outcomes may be attributed to maternal asthma could identify a key point for intervention to 
help reduce these persistent disparities. In addition, racial/ethnic disparities in obstetric and 
neonatal outcomes among women with asthma are understudied. One prior study examined 
the impact of maternal asthma on obstetric and neonatal outcomes by race/ethnicity, but this 
nation-wide US effort did not consider the underlying differences in outcome prevalence by 
race among women without asthma [12]. We addressed this gap in knowledge by examining 




The Consortium on Safe Labor (CSL) was a retrospective cohort of US deliveries between 
2002 and 2008 [13]. The CSL took place across 12 clinical sites (19 medical centers) 
covering nine American College of Obstetricians and Gynecologists (ACOG) districts. We 
obtained data on 223,512 singleton deliveries. For this analysis, participants were excluded 
if their race/ethnicity was listed as multi-racial (n = 343), other (n = 4,888) or was unknown/
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missing (n = 9,382). Thus, our cohort for analysis consisted of 208,899 singleton deliveries, 
and included racial/ethnic groups of White (n = 110,603, 52.9%), Black (n = 50,284, 
24.1%), Hispanic (n = 38,831, 18.3%) and Asian/Pacific Islanders (n = 9,181, 4.4%). Race/
ethnicity was recorded in the EMR and is assumed to be self-reported. The reporting 
suggests that women of Hispanic ethnicity could be of any race. Most women contributed 
only one pregnancy (n = 191,071, 91.5%). Asthma status was based on International 
Classification of Diseases, 9th edition (ICD-9) codes or delivery records and participants 
could contribute deliveries to both groups if they were diagnosed with asthma between 
pregnancies. Institutional review board approval was obtained by all participating 
institutions.
Main Outcomes
Data on maternal demographics, medical history, obstetric and neonatal outcomes were 
obtained from electronic medical records (EMRs) supplemented with International 
Classification of Diseases, 9th edition (ICD-9) codes in hospital discharge summaries. Codes 
used to identify complications have been previously described [5, 14]. We evaluated 
neonatal and obstetric outcomes previously identified in our data as being associated with 
maternal asthma and retained outcomes with sufficient numbers to support analyses by race/
ethnicity [5, 14]. Obstetric outcomes examined included gestational diabetes, gestational 
hypertension, preeclampsia, maternal hemorrhage, placental abruption, premature rupture of 
membranes (PROM) and preterm premature rupture of membranes (PPROM < 37 
gestational weeks), and preterm delivery (<37 weeks). Neonatal outcomes examined 
included neonatal intensive care unit (NICU) admission, apnea, respiratory distress 
syndrome, transient tachypnea of the newborn, anemia, small for gestational age (SGA), and 
hyperbilirubinemia. SGA was defined as the lowest 10% of birth weight for age and sex of 
the distribution of birth weight in our population [15].
Statistical Analyses
Descriptive statistics were calculated to summarize the demographic and clinical 
characteristics of women by race/ethnicity. We examined differences in the distribution of 
categorical demographic and clinical factors, including maternal asthma across race/
ethnicity groups using chi-square tests. The difference in mean maternal age across groups 
was examined using a Kruskal-Wallis test. We also calculated the prevalence of obstetric 
and neonatal complications among women with and without asthma across race/ethnicity 
groups. While we present the prevalence of obstetric and neonatal complications for all 
groups, sample size limitations did not allow us to examine the interaction between asthma 
and race/ethnicity for Asian/Pacific Islander women.
We examined the main effects of maternal race/ethnicity together with asthma status on the 
odds of obstetric and neonatal complications. Adjusted odds ratios (aOR) and their 95% 
confidence intervals (95% CIs) were estimated with multi-level logistic regression using 
generalized estimating equations (GEE) and a first-order autoregressive covariance 
structure, adjusting for demographic and clinical variables. This allowed us to account for 
correlation among women who contributed more than one pregnancy throughout the study 
period. We tested for interaction between maternal race/ethnicity and asthma status and 
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considered a p-value of <0.05 as statistically significant. To ease interpretation and allow for 
comparison across groups, odds ratios for a given complication for racial/ethnic groups were 
derived from the same logistic regression model. To account for the varying prevalence of 
maternal asthma rates and obstetric and neonatal complications across groups, we chose to 
use women of the same racial/ethnic group without asthma as the reference group for 
comparisons. Except where noted, odds ratios were adjusted for covariates available in the 
electronic medical record selected a priori based on our previous studies of obstetric and 
neonatal complications among women with asthma [5,14]. These covariates included 
maternal age (continuous), marital status (not married/married/missing), insurance (private/
public/other/missing), pre-pregnancy body mass index in kg/m2 (under: <18.5, normal: 18.5 
to <25, overweight: 25 to <30, obese: 30 to <35, severely obese: ≥35), smoking (yes/no) and 
alcohol use (yes/no) during pregnancy, history of chronic disease (pre-pregnancy diabetes, 
chronic hypertension, thyroid disease, or human immunodeficiency virus), parity 
(nulliparous/multiparous), cesarean delivery (yes/no), and clinical site.
We excluded women with pre-existing chronic disease from specific analyses when 
appropriate. In the model for gestational diabetes, we excluded women with (n=362, 2.3%) 
and without asthma (n=2,695, 1.4%) with a pre-pregnancy diabetes diagnosis. Similarly, 
women with a prior diagnosis of hypertension were excluded from models for gestational 
hypertension. This included 479 (3%) and 3,665 (1.8%) women with and without asthma, 
respectively. Birthweight was missing or implausible for 2,393 patients, including 130 
(0.8%) and 2,263 (1.2%) mothers with and without asthma, respectively. We excluded these 
deliveries from the analyses for SGA and used infants that were appropriate for gestational 
age (AGA) as the reference category. Information on infant apnea was not recorded at one 
clinical site and we therefore excluded this site in analyses for this outcome (n = 19,708, 
9.4%). We also conducted supplemental analyses using similar methods to compare the 
outcomes of non-White mothers using White mothers (with and without asthma) as the 
reference group. All statistical analyses were performed using SAS (version 9.3; SAS, Cary, 
NC).
Results
Overall, 7.7% of pregnancies were complicated by maternal asthma (n=16,099). Asthma 
prevalence differed significantly across racial/ethnic groups (p<.0001). Black women had 
the highest prevalence of asthma (10.8%) followed by Whites (7.4%), Hispanics (5.9%) and 
Asian/Pacific Islanders (2.3%) (Table 1). Black women appeared to be younger, more 
frequently unmarried and experienced more prior chronic disease during pregnancy 
compared with other racial/ethnic groups.
As anticipated, obstetric and neonatal complications were generally more frequent among 
pregnancies complicated by maternal asthma across all race/ethnicities (Table 2). Except for 
maternal hemorrhage, the prevalence of complications was found to be statistically different 
across categories of race/ethnicity (main effect of race p<0.05). Gestational diabetes was 
more prevalent among Hispanic and Asian/Pacific Islanders, while these groups have lower 
rates of gestational hypertension. Preterm birth was more prevalent among Black and 
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Hispanic mothers and many neonatal complications were higher among Black infants. In 
contrast, hyperbilirubinemia was higher in White and Asian/Pacific Islander infants.
Significant interactions between maternal asthma and race/ethnicity (p<0.05) were only 
observed for two of the eight obstetric complications examined (Table 2): preeclampsia and 
maternal hemorrhage. White women with asthma were more likely to experience 
preeclampsia (aOR 1.28; 95% CI 1.15–1.43) and maternal hemorrhage (aOR 1.14; 1.04–
1.23) when compared to their non-asthmatic counterparts (Table 3). Obstetric complications 
among Black women did not differ by asthma status. Using White mothers as the reference 
group (Supplemental Table 1), risks for non-White women with asthma were generally 
similar to White women and attenuated compared to the findings for non-asthmatics.
Significant interactions between maternal asthma and race/ethnicity were found for three of 
the seven neonatal outcomes examined (Table 2): NICU admission, apnea and SGA. 
Newborns of White and Hispanic mothers with asthma were found to be at an increased 
odds of NICU admission (aOR 1.19; 1.11–1.28; 1.16; 1.02–1.32, respectively) and SGA 
(aOR 1.11; 1.02–1.20; 1.26; 1.10–1.44, respectively) (Table 3). Additionally, newborns of 
Hispanic women with asthma were more likely to experience apnea (aOR 1.32; 1.02–1.69). 
Black women with asthma were not observed to be at increased odds of neonatal 
complications when compared to their non-asthmatic counterparts. When the infants of 
White mothers with asthma were used as the comparison group (Supplemental Table 1), we 
observed the anticipated pattern of risk among non-asthmatics. Among the infants of 
asthmatics, we observed fewer differences by race/ethnicity. Black infants were less likely 
to have apnea and hyperbilirubinemia, but more likely to have anemia and term low birth 
weight. Both Black and Asian/Pacific Islander infants of asthmatic mothers were less likely 
to have a term birth weight >4000 grams. Hyperbilirubinema was lower among Asian/
Pacific Islander infants. Similar to our findings with obstetric complications, risk estimates 
among asthmatics were generally attenuated compared to non-asthmatics.
Discussion
In this large retrospective cohort study of US deliveries, we found that maternal asthma does 
not appear to impact the risk of most obstetric and neonatal complications within racial/
ethnic groups. However, a few notable risks for White and Hispanic women were observed. 
Compared to their non-asthmatic counterparts, White women with asthma were found to be 
at increased odds of preeclampsia and maternal hemorrhage. NICU admission and SGA 
were more frequent among newborns born to White and Hispanic mothers. Furthermore, the 
odds of apnea were greater among newborns born to Hispanic mothers with asthma 
compared to non-asthmatics. However, we did not find statistical interaction between 
maternal/race ethnicity and asthma status for six of the eight obstetric and four of the seven 
neonatal complications examined. Also, despite the high prevalence of maternal asthma as 
well as obstetric and neonatal complications among Black women and their offspring, we 
did not observe an increased risk of complications among Black women or their newborns 
associated with asthma. This is very reassuring and also indicates that maternal asthma may 
do little to explain the between group disparities in obstetric and neonatal outcomes among 
racial/ethnic groups.
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While Black women have higher rates of asthma and experience higher rates of obstetric and 
neonatal complications compared to Whites, we did not see a significant change in adverse 
outcome risk among Black women with asthma compared to Black women without asthma 
[6, 16–22]. Previous findings have indicated that Black women experience high rates of 
psychosocial risks such as depression, stress, racial discrimination and racism during 
pregnancy [22–29]. Reassuringly, our findings suggest that the high rate of maternal asthma 
among Black women is not significantly contributing to their adverse outcome risk. Given 
their known risks, Black women with asthma may be more frequently or closely monitored 
during prenatal care or perhaps given the large number of competing risks among Black 
women, having asthma does not further impact their risk of complications.
Our findings suggest that maternal asthma may not be a significant contributor to the racial/
ethnic disparities in obstetric and neonatal complications in the US. A meta-analysis 
summarizing the evidence for factors contributing to racial/ethnic disparities in obstetric 
outcomes grouped factors into five domains which included biology, social circumstances, 
environmental exposures, behavioral patterns and medical care [30]. The large number of 
competing risks may explain why maternal asthma does not seem to differentially impact the 
risk of obstetric and neonatal complications across racial ethnic groups, especially among 
Black women. Our clinical data does not allow for investigation of important social factors 
such as poverty in our analyses.
The relationship between maternal asthma and obstetric and neonatal outcomes has been 
widely studied, but differences across race/ethnicity have not been examined [3, 5, 14, 31–
39]. To the best of our knowledge, our study is the first to investigate the joint effects of 
maternal asthma by maternal race/ethnicity on the odds of obstetric and neonatal 
complications. One prior study that investigated health disparities in maternal asthma used 
White women as the comparison group instead of assessing the within group difference 
between racial/ethnic groups [12]. We also observed that asthma prevalence is found to vary 
widely across racial/ethnic groups and we decided to explore the impact maternal asthma 
had on the within-group risk of obstetric and neonatal complications examined.
In general, compared to data on asthmatic women from the National Inpatient Sample (NIS), 
we observed higher prevalence for some obstetric complications including gestational 
diabetes (Asian/Pacific Islanders 11.3 vs 7.2%), preeclampsia (Whites 5.3 vs 1.6%), PROM 
(Hispanic 8.2 vs 2.9%) and postpartum hemorrhage (Whites 8.7 vs 2.7%) [12]. The 
increased rates may be due to differences in the study design and population. The NIS 
collects data from the Healthcare Cost and Utilization Project (HCUP) and only included 
discharge data, as opposed to our study that had access to both EMRs and discharge data. 
This may have allowed us to better capture the outcomes examined. Additionally, temporal 
changes in recordkeeping or diagnostics could have influenced these differences. The NIS 
study was conducted between 1998–1999 and the CSL was conducted from 2002 to 2008.
There were several limitations to our study that should be considered. We did not have a 
sufficient sample of Asian Americans to evaluate the differential impact of asthma on the 
outcomes examined, although our supplemental analysis compares their outcomes to 
Whites. A study in California found differences in obstetric outcomes exist between Asian 
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groups with Cambodians/Laotians having the highest risk profiles compared to Japanese 
[40]. Maternal asthma has also been shown to vary across Hispanic subgroups. Previous 
studies support the finding that Puerto Rican women have higher rates of severe asthma 
compared to other Hispanic women and it is important to examine whether this severity 
impacts neonatal outcomes differentially within Hispanic subgroups [1]. The CSL did not 
capture information on subgroups of Hispanic ethnicity. Our data are nationwide and few 
restrictions for cohort entry were imposed (gestational age ≥23 weeks, for example) with no 
restrictions for race, asthma or complications, although centers were located primarily in 
urban areas. We assume our data are fairly representative of the experience in contemporary 
labor and delivery practice in urban centers.
Similarly, because our study relied on delivery admission EMRs and ICD-9 codes, there was 
no specific information regarding asthma severity, symptoms and medication use. Previous 
studies have found that women with poor asthma control are more likely to experience 
adverse pregnancy outcomes [4, 41]. We were unable to evaluate the joint effects of 
maternal asthma and race/ethnicity among subgroups of women with varying levels of 
asthma control. However, under the assumption that they were more likely to have asthma 
complicating pregnancy, we conducted sensitivity analyses restricting our population to 
women with asthma in their discharge summary. In addition, we excluded sites with the two 
highest and two lowest asthma prevalence in our prior studies [5, 14]. Neither scenario was 
found to impact our findings giving some confidence that our findings are not due to bias in 
reporting by site or complication. Covariate data such as alcohol use and smoking from the 
EMR are also likely to be primarily based on self-report and the prevalence could be 
underestimated.
Despite these limitations, the availability of detailed clinical information in our study has 
helped to provide a better understanding of the complications experienced by women with 
asthma in a racially diverse contemporary US cohort. For the various outcomes examined, 
some data were only available from the EMR, identified via hospital discharge codes, or 
when possible we combined hospital discharge data with data from EMRs. While hospital 
discharge data and EMRs have been found to be accurate sources of pregnancy related 
outcomes, using an additional source to identify outcomes has proven to increase 
ascertainment [42].
While non-White racial/ethnic groups are often more likely to experience obstetric and 
neonatal complications compared to White women, our findings suggest this is not the case 
among women with asthma. Between-group comparisons demonstrated that non-Hispanic 
White women with asthma and their infants had outcomes that were more similar to their 
White counterparts than those without asthma. In addition, we observed that maternal 
asthma did not increase the risk for most of the obstetric and neonatal complications 
examined within non-White racial/ethnic groups.
In conclusion, the results of our study suggest that maternal asthma does not differentially 
impact the prevalence of most of the obstetric and neonatal complications examined across 
racial/ethnic groups. However, given the increased risks observed for White and Hispanic 
women with asthma, particular attention should be given to these women during prenatal 
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care to ensure that their asthma is being managed and controlled to reduce the likelihood of 
obstetric and neonatal complications. Despite the high prevalence of asthma and increased 
risks for complications among Black women, asthma status did not confer additional risks to 
Black women and their infants. Future studies can examine whether asthma does not confer 
additional risks to Black women due to underreporting of complications, competing risks, or 
greater care to control asthma among Black women given their high risk status. We also 
encourage additional study of Asian/Pacific Islander women, a widely understudied 
population in obstetric and neonatal health which we did not have power to fully evaluate in 
these analyses. Future work is needed to confirm our findings, especially given the 
insufficient knowledge on racial/ethnic differences in obstetric and neonatal among 
asthmatic women.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Both asthma and race/ethnicity can increase obstetric and neonatal 
complications.
• We examined asthma-associated risks within race/ethnic groups.
• White asthmatics had higher risk of preeclampsia and hemorrhage than non-
asthmatics.
• NICU admission and SGA risk were higher for White and Hispanic infants of 
asthmatics.
• Asthmatic Black women had similar outcomes as non-asthmatic Black women.
• Maternal asthma is not a major factor in obstetric/neonatal race/ethnic 
disparities.
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Table 3
Adjusted odds ratios and 95% confidence intervals for obstetric and neonatal outcomes among women with 
asthma in the Consortium on Safe Labor within race/ethnicity groups (n = 208,899), 2002–2008a
White Black Hispanic
n = (110,603) n = (50,284) n = (38,831)
aOR (95% CI)
Obstetric outcomes
Preeclampsia 1.28 (1.15, 1.43) 0.91 (0.80, 1.03) 1.03 (0.85, 1.26)
Maternal hemorrhage 1.14 (1.04, 1.23) 1.05 (0.93, 1.18) 1.05 (0.87, 1.26)
Neonatal outcomes
NICU admission 1.19 (1.11, 1.28) 1.02 (0.95, 1.11) 1.16 (1.02, 1.32)
Apnea 1.06 (0.91, 1.24) 0.85 (0.71, 1.00) 1.32 (1.02, 1.69)
Size for gestational age SGA 1.11 (1.02, 1.20) 1.06 (0.98, 1.15) 1.26 (1.10, 1.44)
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; NICU, neonatal intensive care unit; SGA, small for gestational age.
Bold font indicates significant values.
a
Reference group is women without asthma within each racial/ethnic group. Estimates adjusted for asthma status, race/ethnicity, maternal age, 
marital status, insurance, pre-pregnancy body mass index, smoking and alcohol use during pregnancy, history of chronic pre-existing disease, 
parity, cesarean delivery, and clinical site.
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